Mamon A. Obeid

Array ( [id] => 4179268 [patent_doc_number] => 06037322 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-14 [patent_title] => 'Methods for treating vascular disorders using activated protein C' [patent_app_type] => 1 [patent_app_number] => 9/161900 [patent_app_country] => US [patent_app_date] => 1998-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5058 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/037/06037322.pdf [firstpage_image] =>[orig_patent_app_number] => 161900 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4356005 [patent_doc_number] => 06200953 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-13 [patent_title] => 'Relaxin analogs and derivatives compositions' [patent_app_type] => 1 [patent_app_number] => 9/158706 [patent_app_country] => US [patent_app_date] => 1998-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9342 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 188 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/200/06200953.pdf [firstpage_image] =>[orig_patent_app_number] => 158706 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4359204 [patent_doc_number] => 06191107 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-20 [patent_title] => 'Complex of human growth hormone and zinc' [patent_app_type] => 1 [patent_app_number] => 9/151783 [patent_app_country] => US [patent_app_date] => 1998-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 10001 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/191/06191107.pdf [firstpage_image] =>[orig_patent_app_number] => 151783 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4140638 [patent_doc_number] => 06060449 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-09 [patent_title] => 'Neovascularization inhibitor containing tissue factor pathway inhibitor' [patent_app_type] => 1 [patent_app_number] => 9/142479 [patent_app_country] => US [patent_app_date] => 1998-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3074 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/060/06060449.pdf [firstpage_image] =>[orig_patent_app_number] => 142479 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4147027 [patent_doc_number] => 06063762 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-16 [patent_title] => 'Cyclosporin-containing microemulsion preconcentrate composition' [patent_app_type] => 1 [patent_app_number] => 9/146584 [patent_app_country] => US [patent_app_date] => 1998-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8254 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/063/06063762.pdf [firstpage_image] =>[orig_patent_app_number] => 146584 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4031309 [patent_doc_number] => 05994310 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-30 [patent_title] => 'Peptide ligands for affinity purification of human Factor VIII' [patent_app_type] => 1 [patent_app_number] => 9/146402 [patent_app_country] => US [patent_app_date] => 1998-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 12 [patent_no_of_words] => 3608 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/994/05994310.pdf [firstpage_image] =>[orig_patent_app_number] => 146402 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1528430 [patent_doc_number] => 06479523 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-12 [patent_title] => 'Pharmacologic drug combination in vagal-induced asystole' [patent_app_type] => B1 [patent_app_number] => 09/139442 [patent_app_country] => US [patent_app_date] => 1998-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3694 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/479/06479523.pdf [firstpage_image] =>[orig_patent_app_number] => 09139442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1528430 [patent_doc_number] => 06479523 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-12 [patent_title] => 'Pharmacologic drug combination in vagal-induced asystole' [patent_app_type] => B1 [patent_app_number] => 09/139442 [patent_app_country] => US [patent_app_date] => 1998-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3694 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/479/06479523.pdf [firstpage_image] =>[orig_patent_app_number] => 09139442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1528430 [patent_doc_number] => 06479523 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-12 [patent_title] => 'Pharmacologic drug combination in vagal-induced asystole' [patent_app_type] => B1 [patent_app_number] => 09/139442 [patent_app_country] => US [patent_app_date] => 1998-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3694 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/479/06479523.pdf [firstpage_image] =>[orig_patent_app_number] => 09139442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1528430 [patent_doc_number] => 06479523 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-12 [patent_title] => 'Pharmacologic drug combination in vagal-induced asystole' [patent_app_type] => B1 [patent_app_number] => 09/139442 [patent_app_country] => US [patent_app_date] => 1998-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3694 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/479/06479523.pdf [firstpage_image] =>[orig_patent_app_number] => 09139442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4287997 [patent_doc_number] => 06211155 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-03 [patent_title] => 'Peptide conjugates derived from thymic hormones, their use as a medicament and compositions containing them' [patent_app_type] => 1 [patent_app_number] => 9/068767 [patent_app_country] => US [patent_app_date] => 1998-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 11 [patent_no_of_words] => 8214 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/211/06211155.pdf [firstpage_image] =>[orig_patent_app_number] => 068767 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4105629 [patent_doc_number] => 06051683 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-18 [patent_title] => 'Immune regulating peptides and method of obtaining them' [patent_app_type] => 1 [patent_app_number] => 8/894963 [patent_app_country] => US [patent_app_date] => 1998-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1861 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/051/06051683.pdf [firstpage_image] =>[orig_patent_app_number] => 894963 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3998775 [patent_doc_number] => 05986048 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-16 [patent_title] => 'Process for obtaining insulin precursors having correctly bonded cystine bridges' [patent_app_type] => 1 [patent_app_number] => 9/134836 [patent_app_country] => US [patent_app_date] => 1998-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6022 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 197 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/986/05986048.pdf [firstpage_image] =>[orig_patent_app_number] => 134836 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1494463 [patent_doc_number] => 06342477 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-29 [patent_title] => 'Remedies for thrombocytopenia' [patent_app_type] => B1 [patent_app_number] => 09/117379 [patent_app_country] => US [patent_app_date] => 1998-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 2921 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/342/06342477.pdf [firstpage_image] =>[orig_patent_app_number] => 09117379 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4107780 [patent_doc_number] => 06022858 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-08 [patent_title] => 'Pharmaceutical formulation of human-growth hormone pretreated with zinc salt' [patent_app_type] => 1 [patent_app_number] => 9/121386 [patent_app_country] => US [patent_app_date] => 1998-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3636 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/022/06022858.pdf [firstpage_image] =>[orig_patent_app_number] => 121386 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4086810 [patent_doc_number] => 06017876 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-25 [patent_title] => 'Chemical modification of granulocyte-colony stimulating factor (G-CSF) bioactivity' [patent_app_type] => 1 [patent_app_number] => 9/119800 [patent_app_country] => US [patent_app_date] => 1998-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 7794 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/017/06017876.pdf [firstpage_image] =>[orig_patent_app_number] => 119800 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4237187 [patent_doc_number] => 06165980 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-26 [patent_title] => 'Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents' [patent_app_type] => 1 [patent_app_number] => 9/101758 [patent_app_country] => US [patent_app_date] => 1998-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23223 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/165/06165980.pdf [firstpage_image] =>[orig_patent_app_number] => 101758 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4251732 [patent_doc_number] => 06207639 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-27 [patent_title] => 'Compounds and methods for modulating neurite outgrowth' [patent_app_type] => 1 [patent_app_number] => 9/115395 [patent_app_country] => US [patent_app_date] => 1998-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 14232 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/207/06207639.pdf [firstpage_image] =>[orig_patent_app_number] => 115395 [rel_patent_id] =>[rel_patent_doc_number] =>)